Mallinckrodt and Endo to combine in stock and cash transaction

cagkansayin Specialty pharmaceutical companies Endo, Inc. ( OTC:ENDPQ ) and Mallinckrodt ( OTC:MNKTQ ) announced Thursday plans to combine in a stock and cash transaction worth $6.7B, creating a public firm listed on the New York Stock Exchange.

Per the terms, Endo ( OTCQX:NDOI ) shareholders.